Comprehensive Analysis for Improvement of the Therapeutic Outcome against Esophageal Cancer by the High-Precision Molecular and Genetic Evaluation

高精度分子遗传评价综合分析食管癌治疗效果的改善

基本信息

  • 批准号:
    21229015
  • 负责人:
  • 金额:
    $ 135.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
  • 财政年份:
    2009
  • 资助国家:
    日本
  • 起止时间:
    2009-05-11 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

To obtain a landscape of genomic alterations in ESCC, we performed whole-exome sequencing on 144 paired DNA samples from Japanese cohort, combined with SNP-array based CN profiling. Substitution patterns of single-nucleotide mutations substantially vary among cases, and the variation was significantly associated with not only alcohol and tobacco consumption, but also related genetic factors: ALDH2 and CYP2A6 polymorphisms. We also identified TP53, NOTCH1, MLL2, NFE2L2, etc. as significantly mutated genes. Moreover, TET2 and NFE2L2 mutations contribute to the malignancy by upregulating invasiveness and oxidoreductase activity, respectively. Finally, our pathway-level analysis shows that genomic alteration are dispersed across cancer-associated pathways including cell cycle, epigenetic regulators, NOTCH, RTK-PI3K pathways etc. Collectively, this study contributes to understanding of ESCC pathophysiology and provides a new basis for designing novel therapeutic strategies.
为了获得ESCC中基因组改变的景观,我们对日本同胞的144个配对DNA样品进行了全外观测序,并结合了基于SNP阵列的CN分析。单个核苷酸突变的替代模式在病例中有很大变化,并且这种变化不仅与酒精和烟草的消费量显着相关,还与相关的遗传因素相关:ALDH2和CYP2A6多态性。我们还将TP53,Notch1,Mll2,NFE2L2等确定为显着突变的基因。此外,TET2和NFE2L2突变分别通过上调侵袭性和氧化还原酶活性来促进恶性肿瘤。最后,我们的途径级分析表明,基因组改变分散在癌症相关的途径之间,包括细胞周期,表观遗传调节剂,Notch,RTK-PI3K途径等,这项研究有助于理解ESCC病理生理学,并为设计新的治疗策略提供新的基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
進行癌はなぜ治りにくいか?-癌幹細胞からの知見-
为什么晚期癌症难以治愈? - 癌症干细胞的知识 -
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yamamoto;M.;Saito;T.;Isogai;A.;Kurita;M.;Kondo;T.;et al.;森正樹
  • 通讯作者:
    森正樹
癌の転移・浸潤メカニズムの解明に向けて~マウスモデルを用いた研究で世界をリード~
阐明癌症转移和侵袭的机制 - 小鼠模型研究处于世界领先地位 -
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hasegawa H;Fujita T;et al.;森正樹
  • 通讯作者:
    森正樹
再発3
复发3
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    小林ゆり;齋藤継之;磯貝 明;Fujita T;森正樹
  • 通讯作者:
    森正樹
Strong interaction between alcohol drinking and smoking habits on ESCC was observed among only individuals having ADH1B and/or ALDH2 variants
仅在具有 ADH1B 和/或 ALDH2 变异的个体中观察到饮酒和吸烟习惯对 ESCC 的强烈相互作用
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tanaka F;Yamamoto K;Suzuki S;Inoue H;Koshi Mimori;Ishii H;Mori M;Kiban S team
  • 通讯作者:
    Kiban S team
がん転移の病態と治療
癌症转移的病理学和治疗
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Keita Emura;Atsuko Miyaji;and Kazumasa Omote;中尾一和;森正樹
  • 通讯作者:
    森正樹
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORI Masaki其他文献

MORI Masaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORI Masaki', 18)}}的其他基金

Achievement of highly accurate diagnosis of early pancreatic cancer in Japanese patients through a comprehensive/integrated approach
通过综合/综合方法实现日本患者早期胰腺癌的高精度诊断
  • 批准号:
    15H05791
  • 财政年份:
    2015
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Noveltechnology for imuse cell induction.
imuse细胞诱导新技术。
  • 批准号:
    23659648
  • 财政年份:
    2011
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Comparison research on building strategy of overseas Chinese enterprises under economic environments in three east Asian countries
东亚三国经济环境下华侨企业建设策略比较研究
  • 批准号:
    22730318
  • 财政年份:
    2010
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Exploration of high-energy emission mechanism of the Galactic objects with Fermi Gamma-ray Space Telescope Data
利用费米伽马射线空间望远镜数据探索银河系天体高能发射机制
  • 批准号:
    22540315
  • 财政年份:
    2010
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploration of Galactic Cosmic-ray Origin with High Angular/Energy Resolution TeV Gamma-ray Observation
利用高角/能量分辨率 TeV 伽马射线观测探索银河宇宙线起源
  • 批准号:
    17204015
  • 财政年份:
    2005
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analyses of disease resistance mechanism by rice acyltransferase family
水稻酰基转移酶家族抗病机制分析
  • 批准号:
    17580087
  • 财政年份:
    2005
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer
食管癌治疗的分子遗传学和分子流行病学研究
  • 批准号:
    17109013
  • 财政年份:
    2005
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Establishment of melecular-based diagnositics for esophageal cancer
食管癌分子诊断学的建立
  • 批准号:
    15390398
  • 财政年份:
    2003
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Gene therapy for chronic granulomatous disease combined with in vivo expansion of transduced hematopoietic cells.
慢性肉芽肿性疾病的基因治疗结合转导造血细胞的体内扩增。
  • 批准号:
    14570993
  • 财政年份:
    2002
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Simultaneous observation of TeV time-variable objects and gamma-ray burst afterglows with an optical telescope
用光学望远镜同时观测TeV时变物体和伽马射线暴余辉
  • 批准号:
    14540248
  • 财政年份:
    2002
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

TKI抵抗性CMLに対するエキソーム解析とFRET解析の統合による個別化治療の可能性
通过整合外显子组分析和 FRET 分析对 TKI 耐药 CML 进行个性化治疗的可能性
  • 批准号:
    24K11508
  • 财政年份:
    2024
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on the identification of target factors for elucidation of the pathogenesis of hypertrophic cardiomyopathy and development of novel treatments
阐明肥厚型心肌病发病机制和开发新疗法的靶标因素的研究
  • 批准号:
    22KJ1699
  • 财政年份:
    2023
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Pilot study for identification of familial lung cancer susceptible genes
家族性肺癌易感基因鉴定初步研究
  • 批准号:
    21K07111
  • 财政年份:
    2021
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploration of clinical phenotype and pathogenic mechanisms of GNAS related disease
GNAS相关疾病的临床表型及发病机制探讨
  • 批准号:
    20K08178
  • 财政年份:
    2020
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exome sequencing of multiplex families to elucidate pathophysiology of autism spectrum disorder
多重家族的外显子组测序阐明自闭症谱系障碍的病理生理学
  • 批准号:
    18K15512
  • 财政年份:
    2020
  • 资助金额:
    $ 135.37万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了